title: Severe neutropenia associated with oral terbinafine therapy.
authors.affiliation: Department of Medicine, Sunnybrook Health Science Center and the University of Toronto, Ontario, Canada.
authors.forename: A K
authors.initials: AK
authors.lastname: Gupta
authors.forename: G S
authors.initials: GS
authors.lastname: Soori
authors.forename: J Q
authors.initials: JQ
authors.lastname: Del Rosso
authors.forename: P B
authors.initials: PB
authors.lastname: Bartos
authors.forename: N H
authors.initials: NH
authors.lastname: Shear
mesh_terms: D000284:Administration, Oral; D000935:Antifungal Agents / Q000009:adverse effects*; D016470:Bacteremia / Q000382:microbiology; D005533:Foot Dermatoses / Q000188:drug therapy / Q000382:microbiology; D005891:Gingivitis / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects*; D009503:Neutropenia / Q000139:chemically induced*; D014009:Onychomycosis / Q000188:drug therapy; D011552:Pseudomonas Infections; D011550:Pseudomonas aeruginosa; D013203:Staphylococcal Infections; D013280:Stomatitis / Q000139:chemically induced; D000077291:Terbinafine
chemical_list: D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine